JP2023551877A5 - - Google Patents
Info
- Publication number
- JP2023551877A5 JP2023551877A5 JP2023533310A JP2023533310A JP2023551877A5 JP 2023551877 A5 JP2023551877 A5 JP 2023551877A5 JP 2023533310 A JP2023533310 A JP 2023533310A JP 2023533310 A JP2023533310 A JP 2023533310A JP 2023551877 A5 JP2023551877 A5 JP 2023551877A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2020/133598 | 2020-12-03 | ||
| PCT/CN2020/133598 WO2022116086A1 (en) | 2020-12-03 | 2020-12-03 | Bcma-targeted car-t cell therapy for multiple myeloma |
| PCT/CN2021/135295 WO2022117068A1 (en) | 2020-12-03 | 2021-12-03 | Bcma-targeted car-t cell therapy for multiple myeloma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023551877A JP2023551877A (ja) | 2023-12-13 |
| JP2023551877A5 true JP2023551877A5 (https=) | 2024-12-12 |
| JPWO2022117068A5 JPWO2022117068A5 (https=) | 2024-12-12 |
Family
ID=79270135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023533310A Pending JP2023551877A (ja) | 2020-12-03 | 2021-12-03 | Ｂｃｍａを標的とする、多発性骨髄腫のためのｃａｒ－ｔ細胞療法 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20220265710A1 (https=) |
| EP (1) | EP4255450A1 (https=) |
| JP (1) | JP2023551877A (https=) |
| KR (1) | KR20230118556A (https=) |
| CN (1) | CN116888147A (https=) |
| AR (1) | AR124248A1 (https=) |
| AU (1) | AU2021392708A1 (https=) |
| CA (1) | CA3203603A1 (https=) |
| IL (1) | IL303312A (https=) |
| JO (1) | JOP20230122A1 (https=) |
| MA (1) | MA71426A (https=) |
| MX (1) | MX2023006371A (https=) |
| TW (1) | TW202237637A (https=) |
| UY (1) | UY39555A (https=) |
| WO (2) | WO2022116086A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020378263A1 (en) | 2019-11-05 | 2022-06-23 | Janssen Biotech, Inc. | BCMA-targeted CAR-T cell therapy of multiple myeloma |
| CN116096498A (zh) * | 2020-05-04 | 2023-05-09 | 生物诊断有限公司 | 诊断设备 |
| WO2024146398A1 (zh) * | 2023-01-04 | 2024-07-11 | 北京艺妙神州医药科技有限公司 | 分离的抗体、包含该抗体的car及其用途 |
| WO2024206329A1 (en) | 2023-03-27 | 2024-10-03 | Modernatx, Inc. | Nucleic acid molecules encoding bi-specific secreted engagers and uses thereof |
| CA3205511A1 (en) * | 2023-04-19 | 2025-03-17 | Janssen Biotech, Inc. | Bcma-targeted car-t cell therapy for multiple myeloma |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US5019369A (en) | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| CA2096222C (en) | 1990-11-13 | 1998-12-29 | Stephen D. Lupton | Bifunctional selectable fusion genes |
| WO1994028143A1 (en) | 1993-05-21 | 1994-12-08 | Targeted Genetics Corporation | Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene |
| US5814618A (en) | 1993-06-14 | 1998-09-29 | Basf Aktiengesellschaft | Methods for regulating gene expression |
| US5464758A (en) | 1993-06-14 | 1995-11-07 | Gossen; Manfred | Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| US5885827A (en) | 1996-01-23 | 1999-03-23 | The Regents Of The Universtiy Of California | Eukaryotic high rate mutagenesis system |
| FR2814642B1 (fr) | 2000-10-03 | 2005-07-01 | Ass Pour Le Dev De La Rech En | Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee |
| BRPI0807952A2 (pt) | 2007-02-20 | 2014-06-10 | Anaptysbio Inc | Sistemas de hipermutação somática |
| CN105384825B (zh) * | 2015-08-11 | 2018-06-01 | 南京传奇生物科技有限公司 | 一种基于单域抗体的双特异性嵌合抗原受体及其应用 |
| CN105777911B (zh) * | 2016-04-12 | 2019-07-02 | 上海优卡迪生物医药科技有限公司 | 抗bcma嵌合抗原受体、编码基因、重组表达载体及其构建方法和应用 |
| SG10202012157QA (en) * | 2016-06-07 | 2021-01-28 | Max Delbrueck Centrum Fuer Molekulare Medizin Helmholtz Gemeinschaft | Chimeric antigen receptor and car-t cells that bind bcma |
| EP4282877A3 (en) * | 2016-08-10 | 2024-02-21 | Legend Biotech Ireland Limited | Chimeric antigen receptors targeting bcma and methods of use thereof |
| CN108276493B (zh) * | 2016-12-30 | 2023-11-14 | 南京传奇生物科技有限公司 | 一种嵌合抗原受体及其应用 |
| CN108395478A (zh) * | 2017-02-04 | 2018-08-14 | 上海恒润达生生物科技有限公司 | 靶向bcma的嵌合抗原受体并对其双重修饰的方法及其用途 |
| CN119529091A (zh) * | 2018-06-19 | 2025-02-28 | 南京传奇生物科技有限公司 | 工程化的细胞及其用途 |
| JP2021532742A (ja) * | 2018-07-26 | 2021-12-02 | ナンジン レジェンド バイオテック カンパニー, リミテッドNanjing Legend Biotech Co., Ltd. | Ｎｅｆを含むｔ細胞及びその生成方法 |
-
2020
- 2020-12-03 WO PCT/CN2020/133598 patent/WO2022116086A1/en not_active Ceased
-
2021
- 2021-12-02 TW TW110145018A patent/TW202237637A/zh unknown
- 2021-12-02 US US17/540,736 patent/US20220265710A1/en active Pending
- 2021-12-03 CN CN202180080095.0A patent/CN116888147A/zh active Pending
- 2021-12-03 UY UY0001039555A patent/UY39555A/es unknown
- 2021-12-03 MX MX2023006371A patent/MX2023006371A/es unknown
- 2021-12-03 WO PCT/CN2021/135295 patent/WO2022117068A1/en not_active Ceased
- 2021-12-03 IL IL303312A patent/IL303312A/en unknown
- 2021-12-03 US US18/039,420 patent/US20240000836A1/en active Pending
- 2021-12-03 EP EP21838974.0A patent/EP4255450A1/en active Pending
- 2021-12-03 AR ARP210103371A patent/AR124248A1/es unknown
- 2021-12-03 JP JP2023533310A patent/JP2023551877A/ja active Pending
- 2021-12-03 KR KR1020237018245A patent/KR20230118556A/ko active Pending
- 2021-12-03 CA CA3203603A patent/CA3203603A1/en active Pending
- 2021-12-03 MA MA71426A patent/MA71426A/fr unknown
- 2021-12-03 AU AU2021392708A patent/AU2021392708A1/en active Pending
-
2023
- 2023-05-30 JO JOJO/P/2023/0122A patent/JOP20230122A1/ar unknown